Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b21f650fc35b3e1947103e89adb06f3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2014-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bc2e828de7616940fff2a01d18b0b2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17e3504c56eaff2b77bab94c50dc8f6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8e38f928783b648f8c56a3fae8b4b11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_656b6949e046022b25efabf9ace3ef26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba71bb4f57d9c13386fd45d4158bf483 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af5687df29d91445a33360e43de6730d |
publicationDate |
2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10113201-B2 |
titleOfInvention |
Methods and compositions for diagnosis of glioblastoma or a subtype thereof |
abstract |
An isoform-level gene panel is disclosed that can accurately classify a glioblastoma subtype from a tumor sample. Such an isoform level gene panel comprises the 121 to 214 target isoforms identified in Table 1. Also disclosed are reagents for quantitatively detecting the expression or activity of the target isoforms of Table 1 in a patient sample. For example, such ligands can be PCR primer and probes sets. This isoform-level gene panel and reagents for detection of the isoforms are useful in an isoform-level assay for diagnosis of the molecular subtype of a glioblastoma in a patient. The assay employs algorithms and a novel computer program that performs the functions of FIG. 8. In one aspect, the assay is a high-throughput format. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020139866-A3 |
priorityDate |
2013-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |